Bio-Rad Laboratories Inc. (BIO) Misses Q1 EPS by 57c
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $285.28 +1.84%
Revenue Growth %: -7.0%
Financial Fact:
Net sales: 516.78M
Today's EPS Names:
SFST, VLTO, CLIR, More
Revenue Growth %: -7.0%
Financial Fact:
Net sales: 516.78M
Today's EPS Names:
SFST, VLTO, CLIR, More
Join SI Premium – FREE
Bio-Rad Laboratories Inc. (NYSE: BIO) reported Q1 EPS of $0.23, $0.57 worse than the analyst estimate of $0.80. Revenue for the quarter came in at $509 million versus the consensus estimate of $515 million.
For earnings history and earnings-related data on Bio-Rad Laboratories Inc. (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla touts acceleration of new models, but Q1 results fall short of estimates
- IDEX Corp. (IEX) Tops Q1 EPS by 13c ; Offers Guidance
- Avangrid (AGR) Tops Q1 EPS by 19c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
